Company intelligence / Profile preview

HOYA

Shinjuku-ku, Tokyo, Japanhoya.com ↗

Ownership: Private
Employees: ~37000
Development stage: Other

Overview

HOYA has a global commercial presence as a leading provider of intraocular lenses for cataract surgery and endoscopic devices. It also supplies advanced ceramic chromatography media used in the purification of antibody drugs, vaccines, and gene therapies. The company’s medical businesses are mature with ongoing product innovation but do not have a traditional drug development pipeline[1][2][4].

Therapeutic areas: OphthalmologyGastroenterologyOther
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Partnerships

Magentiq Eye Ltd.

Beyond the preview

Go deeper on HOYA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOYA.

Explore the full profile